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The distribution, cell tropism, and cytopathology in vivo of human immunodeficiency virus (HIV) was
investigated in postmortem tissue samples from a series of HIV-infected individuals who died either of
complications associated with AIDS or for unrelated reasons while they were asymptomatic. Proviral sequences
were detected at a high copy number in lymphoid tissue of both presymptomatic patients and patients with
AIDS, whereas significant infection of nonlymphoid tissue such as that from brains, spinal cords, and lungs
was confined to those with AIDS. V3 loop sequences from both groups showed highly restricted sequence
variability and a low overall positive charge of the encoded amino acid sequence compared with those of
standard laboratory isolates of HIV type 1 (HIV-1). The low charge and the restriction in sequence variability
were comparable to those observed with isolates showing a non-syncytium-inducing (NSI) and macrophage-
tropic phenotype in vitro. All patients were either exclusively infected (six of seven cases) or predominantly
infected (one case) with variants with a predicted NSI/macrophage-tropic phenotype, irrespective of the degree
of disease progression. p24 antigen was detected by immunocytochemical staining of paraffin-fixed sections in
the germinal centers within lymphoid tissue, although little or no antigen was found in areas of lymph node
or spleen containing T lymphocytes from either presymptomatic patients or patients with AIDS. The
predominant p24 antigen-expressing cells in the lungs and brains of the patients with AIDS were macrophages
and microglia (in brains), frequently forming multinucleated giant cells (syncytia) even though the V3 loop
sequences of these variants resembled those of NSI isolates in vitro. These studies indicate that lack of
syncytium-forming ability in established T-cell lines does not necessarily predict syncytium-forming ability in
primary target cells in vivo. Furthermore, variants of HIV with V3 sequences characteristic of NSI/
macrophage-tropic isolates form the predominant population in a range of lymphoid and nonlymphoid tissues
in vivo, even in patients with AIDS.
There are several interpretations of the high degree of
observed sequence diversity between published sequences of
the envelope gene of human immunodeficiency virus type 1
(HIV-1) (subtype B) (54) and of the rapid turnover of HIV
envelope variants within infected individuals (69, 79). It has
been suggested that changes in the hypervariable domains in
the env gene (Vi to V5) (52, 70, 78) may facilitate evasion of
the host immune system. This conclusion is supported by the
observation that V3 and possibly other regions are targets of
neutralizing antibodies elicited by natural infection or upon
immunization with recombinant gpl20 protein (20, 26, 32, 44,
49, 60).
However, changes in the V3 loop, and more recently in the
Vi and V2 hypervariable domains, have also been shown to
influence the phenotype of variants of HIV-1 in in vitro culture
(2, 6, 11, 19, 24, 31, 72, 73). In particular, substitutions of basic
amino acids in the V2 and V3 regions change virus isolates
from non-syncytium-inducing (NSI) isolates to syncytium-in-
ducing (SI) isolates (11, 19, 24) and may confer a reduction in
* Corresponding author. Mailing address: Department of Medical
Microbiology, University of Edinburgh, Medical School, Teviot Place,
Edinburgh EH8 9AG, United Kingdom. Phone: (44) 31 650 3138. Fax:
(44) 31 650 6531.
the ability of the virus to replicate in macrophages (10, 64).
Apart from the association with arginine or lysine at positions
11 and 28 in V3, the SI phenotype has been also been shown to
correlate with increased V3 sequence heterogeneity in this
region (10, 51). V3 sequences from NSI isolates show few
sequence differences from each other or from a consensus
sequence of 133 North American isolates (40) that comprise
predominantly subtype B variants of HIV-1 (46). In contrast,
SI isolates show a broad range of substitutions, insertions, and
deletions at most positions (30 of a total of 33 to 37) between
the disulfide-bridged cysteine residues of the putative V3 loop
structure.
In early infection, HIV variants with an NSI/macrophage-
tropic (MT) phenotype predominate. Subsequently, approxi-
mately half of those individuals who progress to AIDS show a
change in virus to a more rapidly replicating (rapid/high) and
cytopathic phenotype (3, 8, 18, 74); this switch in phenotype
has been reported to precede an accelerated loss of CD4+
lymphocytes in the peripheral circulation and a more rapid
onset of AIDS than in those individuals whose isolates retain
the NSI phenotype (35). However, although most investigators
have found a close association between the properties of
syncytium induction and inability to replicate in macrophages
in vitro and vice versa (10, 12, 19, 23, 37, 63, 64, 87), others
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have found that disease progression is associated with a switch
from NSI, non-MT isolates to SI/MT isolates (8).
Despite their more aggressive phenotype in vitro, the SI
isolates are less transmissible by sexual contact than are NSI
isolates (59, 87), but they are equally transmissible in cases of
mother-to-child transmission (62). To explain these apparently
contradictory findings, it has been speculated that macro-
phages may be the first cells infected at the mucosal barrier in
the case of sexual transmission and that infection of this cell
type is responsible for the systemic dissemination of the virus
found upon primary infection (87). However, V3 sequences
typical of NSI isolates were also found to be specifically
selected for not only upon sexual contact but also in several
cases of parenteral infection (hemophiliacs exposed to HIV-
contaminated factor VIII concentrate) in which case the
initially infected cells could equally well be CD4+ lymphocytes
(85).
An important limitation of many of the previous studies of
sequence and phenotype change of HIV-1 is the reliance upon
patient blood samples as sources of virus isolates, proviral
DNA, or virion RNA as study material. However, HIV results
in systemic disease and has been shown to be capable of
infecting a wide variety of nonlymphoid tissue, including tissue
from brain, lung, and the small and large bowel (reviewed in
reference 41). It cannot be assumed that variants in blood are
representative of populations infecting other cell types in the
body. For example, isolates from brain and bowel tissues show
in vitro properties different from those derived from peripheral
blood mononuclear cells (PBMCs); the latter tend to replicate
well in macrophages and to show an NSI phenotype (25, 36,
76). In some cases, sequence differences between populations
of variants in brain tissue and those in circulating lymphoid
cells have been observed (16, 25, 33, 42, 43, 57, 71). The extent
to which sequence changes are responsible for the differences
in in vivo tropism is discussed below.
Given the evidence for changes in the in vitro phenotype of
virus isolated from PBMCs at different stages of disease
progression, it is clearly important to investigate whether
equivalent changes occur in virus populations outside the
peripheral circulation. By carrying out detailed quantitative
studies of postmortem tissue, we have recently found a highly
restricted distribution of HIV in the body preceding the onset
of AIDS, with proviral sequences apparently confined to cells
of the lymphoid system (PBMCs, spleen, and lymph nodes). In
contrast, those patients who died from complications associ-
ated with AIDS showed significant infection of cells in the
central nervous system (CNS) and in lung and bowel tissues
(13). These results confirm a previous study in which HIV
infection was undetectable in the CNS of a large number of
individuals who died while they were asymptomatic (5).
This apparent redistribution of virus upon disease progres-
sion occurs at the same stage of disease as the change from an
NSI to an SI phenotype. Paradoxically, while isolates become
cytopathic and often non-MT in vitro, the redistribution of
HIV in vivo involves organs such as brains and lungs and other
tissues in which the main targets of infection are reported to be
tissue macrophages, microglia (in the CNS), and other non-
lymphocyte cell types (22, 34, 47, 55, 77).
In this study, we have carried out detailed sequence com-
parisons of the V3 loop and flanking regions of virus variants
in lymphoid and nonlymphoid tissues from a series of individ-
uals who died while asymptomatic or as a consequence of
terminal AIDS. The inferred in vitro phenotypes were com-
pared for individuals with differing degrees of disease progres-
sion and for different tissue types in order to explore the
relationship between V3 variation and tissue tropism of HIV in
vivo. In many cases it was possible to directly identify the target
cells and degrees of associated cytopathology in different
tissues (in vivo phenotype) by immunocytochemical staining of
the tissues with an anti-p24 monoclonal antibody.
MATERIALS AND METHODS
Patient samples. Cardiac blood and tissue from various
organs were obtained within 3 days of patient death from 11
autopsied HIV-infected patients of whom three (patients 1 to
3) died suddenly while they were in the asymptomatic stage of
HIV infection as defined by Centers for Disease Control
criteria and four patients (patients 4 through 6 and patient 9)
who died with AIDS-defining illness. Additional lymph node
samples were obtained from four further patients who died of
complications associated with AIDS (patients 10 through 13)
for further sequence comparisons of sequences in the V3 and
gag regions. Clinical information and laboratory investigations
pertaining to patients 1 to 6 have been detailed as part of an
earlier study (13). Patient 9 was a 59-year-old male with a
recent history of psychomotor slowing. One week prior to
death he developed a fatal atypical pneumonia, at which time
a diagnosis of full-blown AIDS was made. He received no
antiviral treatment, and the duration of his infection is un-
known.
Samples of brain (left frontal lobe), spinal cord (mid-
thoracic), lung, large bowel, mesenteric lymph node, and
spleen tissues from these patients were dissected into 1- to
2-cm pieces and were stored at -70°C. DNA was extracted
from tissues and whole blood to obtain total DNA from all
nucleated cells in the circulation (peripheral blood nucleated
cells [PBNCs]) as previously described (68).
Quantitation. Proviral DNA was quantified by using a
previously described limiting dilution and nested-primer PCR
approach (68). The quantitation was performed in the first
instance by using primers corresponding to the pol gene and
was performed subsequently with primers spanning the V3
region. The nucleotide sequences of the primers and the
position of the 5' base in the HXB2 genome (54) were pol a
CATGGGTACCAGCACACCGG, + (sense), position 4149;
pol b GGAGGAAATGAACAAGTAGATA, +, 4175; pol c
TCACTAGCCATTGCTCTCCAATT, - (antisense), 4290;
pol d TCTACTTGTCCATGCATGGCTTC, -, 4380; V3 e TA
CAATGTACACATGGAATT, +, 6957; V3 f TGGCAG
TCTAGCAGAAGAAG, +, 7009; V3 g CTGGGTCCCCTC
CTGAGG, -, 7331; and V3 h ATTACAGTAGAAAAATTC
CCC, -, 7381.
All reactions were performed with appropriate positive and
negative controls. The number of proviral copies was estimated
by assuming a Poisson distribution for each sample by
-log(1-p)Id (where p = proportion of positive samples and d
= dilution). Likelihood ratio tests were used to determine
whether there were significant differences between sample
pairs. The likelihood function is proportional to [1 -exp(Xd)]'
x [exp(-Xd)]n, where X = number of proviral copies, m =
number of positive replicates, and n = number of negative
replicates. Ninety-five percent confidence intervals for each
sample were determined by evaluating the likelihood function
incrementally over the range of possible values for the number
of proviral copies. The overall level of agreement between the
pol and env primers was assessed by using the paired t test on
the basis of the numbers of proviral copies on a log scale.
Sequence analysis. Single molecules of HIV-1 provirus were
isolated by limiting dilution and amplified in a nested PCR to
produce sufficient DNA to allow direct sequencing of the PCR
products. Direct sequencing of amplified DNA was achieved
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TABLE 1. Quantitation of proviral sequences in postmortem tissue by limiting dilution using nested primers in the pol and V3 regions:
frequency of positive results at specified dilutions of DNA
Frequency" of positive results
Patient Primer" Lymphoid tissue Nonlymphoid tissue
Lymph node Spleen PBNCs Brain Spinal cord Lung Colon
Presymptomatic
I E 9/20 (1E-3)' 4/20 (1E-3) 12/20 (1E-2) 0/20 (5E-1) 3/20 (5E-1) 0/20 (5E-1) 0/20 (5E-1)
P 19/60 (5E-4) NDd 18/25 (2E-2 ND ND ND ND
2 E 14/20 (1E-3) 12/20 (1E-2) 7/20 (1E-3) 2/20 (5E-1) 15/20 (5E-1) 6/20 (IE-l) 10/20 (IE-1)
P ND ND 20/50 (2E-3) ND ND ND ND
3 E 9/20 (lE-1) 7/20 (1E-2) 9/20 (1E-2) 3/20 (SE-1) 3/20 (SE-I) 3/20 (lE-1) 6/20 (SE-i)
P 2/20 (5E-2) ND 8/30 (1E-2) ND ND ND ND
Symptomatic
4 E 14/20 (5E-3) 3/20 (1E-3) 5/20 (1E-2) 3/20 (1E-2) 7/20 (IE-2) 18/20 (lE-2) 17/20 (1E-2)
P 19/30 (6E-3) 16/30 (SE-3) 21/50 (5E-2) 17/50 (2E-2) 10/25 (lE-2) 14/49 (2E-3) 18/30 (6E-3)
S E 17/20 (1E-3) 4/20 (IE-3) 7/20 (lE-1) 4/20 (1E-3) 11/20 (1E-4) 17/20 (53-3) 7/20 (IE-1)
P 41/50 (1E-3) ND 23/50 (1.SE-1) 16/50 (1E-3) ND 14/50 (8E-4) ND
6 E 15/20 (1E-2) 19/20 (1E-2) 4/20 (SE-1) 12/20 (1E-2) 10/20 (lE-1) 11/20 (lE-1) 11/20 (lE-3)
P 23/50 (5E-3) ND 1/20 (SE-2) 14/50 (4E-3) ND ND 12/50 (8E-4)
9 E 7/50 (2E-2) ND ND 22/49 (2.5E-4) ND ND ND
p ND ND 03/ (1)' ND 2/3 (lE-2)' 0/3 (1)' 0/3 (1)'
E, enm' primer quantitation; P, pol primer quantitation.
"Expressed as number positive/total number.
'Test dilution (in micrograms); 1E-3 = I x 10- 3ig.
"ND, not done.
'p249'9 quantitation.
either as previously described or by using a solid-phase se-
quencing method (30). For solid-phase sequencing, the second
PCR reaction was performed in a 100-plI volume by using one
biotin-labelled and one unlabelled primer (5 to 10 pmol of
primer per reaction mixture), generating a PCR product with
one strand having a biotin moiety at the 5' end. PCR products
were immobilized on streptavidin-coated magnetic beads (Dy-
nal), and single strands of DNA were purified by magnetic
separation and were sequenced according to the manufactur-
er's protocol.
A Fisher's exact test for 2 x n contingency tables (48) was
used to compare amino acid frequencies at each position in the
V3 loop (n is the number of alternative amino acids at a single
position). The test is based on exact multinomial probabilities
and is appropriate here because many values in the contin-
gency tables were small. Comparisons of V3 loop charge and
diversity were made between sequences obtained in this study
and those of a series of isolates of HIV-1 of known biological
properties. V3 loop sequences of 30 isolates with an SI
phenotype and 29 NSI/MT isolates were obtained from refer-
ences 10 and 19, as were corresponding sequences from MN,
RF, SF2, GUN-1, HAN-2, SF33, LAI, ADA, YU2, SF162,
JF-L, and SF-128A isolates (51, 54).
Evolutionary analysis of p17 sequences. Sequence compar-
isons between viruses from the 11 study patients were made in
the region of the gag gene encoding p17, as previously de-
scribed (29). Phylogenetic relationships between single nucle-
otide sequences from each of the study patients and from
representative sequences obtained both in Edinburgh, United
Kingdom (29a), and from other widely separated geographical
localities (54) were estimated by using the neighbor joining
method with a bootstrap resampling program (PHYLIP pro-
grams SEQBOOT, DNADIST, NEIGHBOR, and CON-
SENSE) (17). Branch lengths on this tree were estimated by
using the maximum-likelihood method (DNAML). Nucleotide
distances between sequences were estimated by using the
substitution model of Felsenstein (program DNADIST).
Immunocytochemical staining. Five-micrometer sections of
formalin-fixed paraffin-embedded tissue from the study organs
were stained with hematoxylin and eosin by standard methods.
p24 antigen was detected by an avidin/biotin immunocyto-
chemical technique (5) with a monoclonal antibody to p24
(Dupont) as first antibody at a dilution of 1/200 and diamino-
benzidine as the visualizing agent. Prior to antibody incuba-
tions, the sections were irradiated in an 800-W microwave oven
for three cycles of 5 min each while they were immersed in 0.01
M citrate buffer (pH 6.0) (Fisons).
Nucleotide sequence accession numbers. Sequences ob-
tained in this study have been deposited into GenBank and
have accession numbers L34422 to L34541.
RESULTS
Quantitation of proviral load in different organs. The
numbers of copies of provirus per million cells in a range of
lymphoid and nonlymphoid tissues from the study patients
were determined by limiting-dilution PCR with primers from
both pol and env regions of the genome (Table 1; results
obtained with the pol primers for patients I to 6 have been
previously reported) (13). We found high levels of HIV in
lymphoid organs (spleen and lymph node) from all presymp-
tomatic and symptomatic individuals with both sets of primers,
whereas nonlymphoid organs were infected only in patients
who died of complications associated with AIDS. Although low
levels of provirus were found in many of the nonlymphoid
tissues of the presymptomatic patients (up to 46 copies per 10"
cells; Table 2), such virus may have originated from PBNCs in
residual blood within the organs (forming between 1 and 10%
of the extracted DNA from the tissue, depending on its
vascularity), as previously discussed (13). For example, the
sample of colon tissue from patient 2 contained 46 copies of
provirus per 106 cells, 60 times lower than the frequency of
infected cells in peripheral blood (2,843 copies per 10' PBNCs)
and attributable to the presence of peripheral blood in the
VOL. 68, 1994
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postmortem tissue. In contrast, the majority of organs from the
patients with AIDS showed high levels of provirus, consistent
with actual infection of cells within the tissue by HIV. Only
samples with clear evidence of infection by these criteria were
used for comparisons of sequences in the env gene (see below).
The accuracy of quantitation by limiting dilution is depen-
dent on the number of replicates tested and the frequency of
positive reactions. We calculated the confidence intervals for
quantitation with pol and env primers by evaluating the likeli-
hood function for each sample (see Materials and Methods)
and found that there was no statistically significant difference
between the primers for any of those tested (Table 2). When
the samples were taken together, the frequency of provirus
quantified with env and pol primers showed a ratio of 1.18
(confidence interval, 0.94 to 1.48; Fig. 1). The correlation
coefficient for quantitation with the two sets of primers was
0.96 (P = 0.0001), and there was no evidence for an over- or
underrepresentation of env or pol sequences in either lym-
phoid or nonlymphoid tissue. These results indicate that the
V3 primers are as efficient as pol primers in amplifying HIV
and that we did not amplify only a specific subset of variants in
our subsequent sequence comparisons (see Discussion).
Sequence variation in the V3 loop. DNA extracted from
different organs or from PBNCs was diluted until only 10 to
20% of replicates gave a PCR product, thus ensuring that
nucleotide sequences were derived from single molecules of
provirus (68). The lack of peripheral infection in the asymp-
tomatic group restricted our sequence comparisons to virus
within lymphoid tissue only (PBNCs and lymph node). For the
patients who died of complications associated with AIDS, we
were able to carry out more extensive comparisons with a
range of samples from nonlymphoid tissues, such as those from
brain and lung tissues (Table 2). None of the 322 nucleotide
sequences in the V3 loop or flanking regions contained inac-
tivating substitutions such as stop codons or frameshifts. Only
one sequence (from lymph node tissue from patient 3) showed
G-*A hypermutation, producing a highly unusual and proba-
bly nonfunctional provirus. Like previous researchers who
used the limiting-dilution/direct-sequencing method of se-
quence determination (4, 68, 85), we have found no evidence
for high rates of defective genomes in vivo.
In the asymptomatic patients, a wide range of sequence
variants were found in both PBNCs and lymph nodes (Fig. 2).
In patients 1 and 3 there were statistically significant differ-
ences in the frequency of major and minor amino acid se-
quences present in the two types of sample. In these two
patients, the majority form, in the PBNCs, differed from that in
the lymph nodes and vice versa, although in each case such
variants were present as minority components in the other
sample.
There was a similar diversity of V3 sequences as well as of
population differences between samples from the patients who
died of complications associated with AIDS. Extreme se-
quence diversity in all samples from patient 4 was observed,
while samples from patient 9 were restricted to only two
different sequences in the brain and to three in the lymph
nodes. As with the presymptomatic patients, the frequencies of
different variants between some organs were statistically sig-
nificant, although a general observation was of a common set
of sequences being present at varying frequencies throughout
the body. For example, for patient 4, the main sequence in the
brain (12 of 17) and spinal cord (6 of 7) also occurred in the
colon (5 of 16), lung (7 of 15), and lymph nodes (1 of 16).
However, there are also variants that appear to be more
restricted in distribution (e.g., the colon of patient 4, the brain
of patient 5, and the colon of patient 6). This type of analysis
J. VIROL.
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provides no evidence for the existence of a shared determinant
in the V3 loop that governs the distribution of HIV variants.
This problem is compounded by not knowing whether the
different sequences within an organ represent genuine diversity
of HIV in a single cell type, or whether they result from the
presence within the same organ of various proportions of
several different HIV-infected cell types, each bearing different
proviral variants (such as CD4+ lymphocytes, dendritic cells,
and macrophages in the lymph nodes).
To investigate in more detail the process of sequence
diversification of the V3 loop upon disease progression, we
compared the number of different V3 amino acid sequences
found within samples from the presymptomatic patient group
and from the group of patients with AIDS (Table 3). In both
cases, frequent nonidentical sequences were found; the pre-
symptomatic patients showed a total of 21 different sequences
of 84 sampled, compared with 18 of 92 in lymphoid tissue and
23 of 146 from nonlymphoid tissue in the patients with AIDS.
Similarly, the mean evolutionary distances between nucleotide
sequences in the presymptomatic group (0.042) differed little
from distances between sequences found in the patients with
AIDS (0.038; Table 4). These comparisons also show that little
difference in diversity exists between populations of HIV
infecting lymphoid tissue and those replicating in nonlymphoid
tissue such as that from the brain, lung, and colon (Tables 3
and 4).
Prediction of in vitro phenotype from V3 loop sequences.
There exist well-defined relationships between the properties
of macrophage tropism and syncytium induction on the one
hand, and between the net V3 charge (11, 19) and similarity to
the subtype B consensus V3 sequence (10) on the other hand.
Comparison of the 54 different V3 loop sequences produced a
consensus sequence that was identical in all but one position to
the subtype B consensus (40). There was a striking similarity
between this set of sequences and a sequence set of 29 isolates
characterized in vitro as showing an MT and NSI phenotype,
not only in overall consensus sequence but also in the position
and nature of amino acid substitutions that did occur (Fig. 3).
For example, both data sets contain frequent substitutions of
asparagine (N) and proline (P) for histidine (H) at position 15
and contain either aspartate (D) or glutamate (E) at position
29, with frequent substitutions of alanine (A) or glutamine (0).
In contrast, V3 loop sequences from a collection of SI
sequences were highly variable and contained a number of
amino acid replacements not found in the other sequences. For
example, residues 7 to 9 are invariant among the postmortem
and NSI/MT sequences but are highly polymorphic in the SI
isolates. Other residues such as that at position 12 show
differences of the consensus sequence (serine [S] in postmor-
tem and NSI/MT sequences and arginine [R] in the SI
variants). To investigate whether the postmortem sequences
were significantly more similar to those of MT isolates, we
carried out Fisher's exact tests (see Materials and Methods) at
each amino acid position in the V3 loop. Results at each amino
acid position are not independent, so statistical results have to
be interpreted cautiously; values are listed only when P is less
than 0.01. These tests showed that between postmortem and
NSI/MT isolates, there were significant differences in the
populations of amino acids only at positions 16 (P 0.003) and
22 (P 10-a) (Fig. 4). In contrast, postmortem sequences
differed significantly at several positions from the SI variants,
the most divergent residues being 10 (P < 10-8), 12 (P <
10-8), and 29 (P < 10-6'). This statistical evidence supports the
previously observed association between the presence of basic
(arginine or lysine) residues at positions 12 and 29 and the SI
phenotype (19), although other types of substitutions at these
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FIG. 1. Comparison of quantitation of provirus by usingpol and V3
primers by limiting dilution (log scales). 0, samples extracted from
lymphoid tissue (lymph node, spleen, and PBNCs); 0, samples ex-
tracted from brain, spinal cord, lung, and colon.
sites also occur specifically in the SI variants. There are also
further positions at which SI variants differ considerably from
postmortem and NSI/MT variants (positions 7 to 10, 15, 28,
and 36).
To investigate the relationship between in vitro phenotype
and V3 sequence, we have calculated the overall V3 charge
and the degree of sequence divergence from the subtype B
consensus for a series of isolates with known biological prop-
erties (Fig. 5a). In agreement with a previous report which
used a similar method for sequence analysis of V3 (51),
NSI/MT isolates consistently showed lower charge, greater
similarity to the subtype B consensus, or both, than did SI and
non-MT variants. A diagonal line almost completely separates
the two populations. Using this analysis to predict the pheno-
type of variants found in postmortem tissue of presymptomatic
and terminal patients with AIDS, we found that almost all
sequences were located to the left of the dividing line and that
they could therefore be predicted to be of the NSI/MT
phenotype (Fig. 5b and c). Indeed, there was a tendency for
some of the postmortem sequences, particularly those from
nonlymphoid tissue, to show a lower charge and fewer differ-
ences from the subtype B consensus than did the "typical" NSI
isolate. The only sequences with overall charge and divergence
approaching that of SI variants were some of those found in
patients 3 and 9.
Although the sequences obtained in this study conform
closely to those previously described for MT variants in vitro,
it is possible that the restriction in sequence diversity in V3
was, at least in part, the result of sampling a population of
individuals infected with a very limited subset of HIV-1
variants. To investigate this possibility, we carried out se-
quence comparisons in the p179a9 for all of the 11 study
patients. Phylogenetic analysis of sequences in the p17 region
have been shown to provide a reliable indication of epidemi-
ological relationships between variants within the same sub-
type B of HIV-1 (27, 29).
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TABLE 3. Comparison of sequence variability in the V3 loop upon
disease progression: frequency of different sequences
No. of sequences
Patient type Lymphoid tissue Nonlymphoid TotaltissueToa
Total Unique Total Unique Total Unique
Presymptomatic 84 21 84 21
Symptomatic 92 18 146 23 238 31
Total 176 36 146 23 322 47
No direct epidemiological relationship was found between
viruses infecting the 11 study subjects (Fig. 6). Although many
of the subjects were infected with variants that fell within the
main (heterosexual and intravenous-drug user) cluster of
Edinburgh patients, there was no evidence of direct epidemi-
ological contact between them. Furthermore, several variants
were separated by those of published isolates of HIV-1 from
North America and elsewhere, suggesting a distant evolution-
ary relationship between them. This analysis confirms the
clinical impression that the patients in this study were unre-
lated epidemiologically to each other. However, there was no
phylogenetic information within the V3 region of the env gene:
sequences showed at most six amino acid changes (patient 9)
from the subtype B consensus sequence. All but one V3
sequence (patient 10) is predicted to have an in vitro NSI/MT
phenotype according to the analysis presented in Fig. 5.
Although certain V3 sequences are more divergent than
others, this does not correlate with the underlying phylogenetic
relationships between the corresponding pl79a9 sequences
within the HIV-1 B subtype.
Localization and cytopathology of HIV-1 in vivo. None of
the previous investigations described in this study identify the
cells infected with HIV. It is therefore not clear whether the
TABLE 4. Comparison of sequence variability in the V3 ioop upon
disease progression: mean sequence diversity
Sequence diversity'
Patient type Lymphoid Nonlymphoid Toa
tissue tissue Total
Presymptomatic 0.042 0.042
Symptomatic 0.038 0.039 0.0385
Total 0.040 0.039 0.040
" Mean evolutionary distance between nucleotide sequences.
predicted macrophage tropism and NSI phenotype of the
postmortem sequences reflects the tropism and cytopathology
of HIV-1 in vivo. To show this, we performed immunocyto-
chemical detection of p24 antigen to localize the infected cells
in the tissues for which we carried out the sequence analysis.
For nonlymphoid tissue, we found a very good agreement
between the detection of p24 antigen and virus load as
determined by limiting-dilution PCR (Table 5). No p24 was
found in nonlymphoid tissue of any of the presymptomatic
patients, while antigen-expressing cells were frequently found
in the brains, spinal cords, and lungs of several of the patients
with AIDS (Tables 1 and 5). For example, patient 5 showed
high levels of provirus and p24 antigen in several organs, while
antigen-expressing cells in patient 6 were confined to the brain.
The lymph node architecture of the presymptomatic patients
was relatively normal or showed hyperplasia (Fig. 7a), with
none of the evident T-cell depletion, involution, or fibrosis
which is found in the lymphoid tissue of patients with AIDS.
The interpretation of p24 antigen staining in lymph nodes and
spleen was complicated by the presence of extracellular virions
captured on the surface of follicular dendritic cells in the B-cell
areas (Fig. 7b) (15, 58). p24 antigen was confined to cellular
processes of what morphologically appeared to be follicular
POST MORTEM VARIANTS
C54TS4RS3P53N44N53N54T54R5K54 * 54S45453 S4H3914l * 54GsG49P54G54R41A54F47Y54T36T54G49D24I54,49G53D471 54R5Q52As4Hs4C54
K1 L1 S6 K1 Gg V1 N1oL13 A4 S13 I4 A16 * E19 T4 E1 N7 K2
G4 P4 El L3 E1 Q6 V1
G, A3
R2
NSI / MACROPHAGE-TROPIC ISOLATES
C29T28R29P2sN28N29N29T29R29K24 .29S27I29.29H17I22.29.29G26P29G29R24A29F20Y29T17T29G2917I29I29G29D25I29R29Q29A29H29C29
I A1 S1 R5 G2 N6 M5 A3 K3 L3 A12 D6 N4 K1
P4 L2 G2 I3 Q
T2 W2 A2
V1
SI / T-CELL LINE-TROPIC ISOLATES
C30T30R3QP30N27N26N21T21R24K51 *25R14I27.27H15I23- 27' 27G30P30G30R29A24F20Y23T22T25G15Q6 27121G29D23124R26Q20A30H26C30
H2 S3 Q3 13 Ks R10R G7 V2 I2 T6 M3 H2 R2 1 V5 V3 H3 A4 A2 R6 E5 R2 V4 N1 N3 L4 3 R5 Y3
Y1 Y1 T3 E3 Q1 14 N1 S6 M1 H1 S2 G1 Q1 I1 D1 L3 R3 .4 12 3 K5 G1 Q2 T3 M2 G1 K4 Q1
Y2 K2 Q1 H3 R2 V1 I2 V1 X1. 3 R5 *2 M1 LI
K1 R1 P1 S1 Y, E2 N5 T1
A11 * D3
I,G
FIG. 3. Comparison of sequences obtained in this study from postmortem material (54 different V3 loop sequences from a total of 322) with
those of isolates of HIV-1 showing an NSI and MT phenotype (n = 29), and isolates that are SI and non-MT (n = 30). Position and frequency
(in subscript) of specific substitutions are indicated below the consensus. See Materials and Methods for sources of sequences.
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FIG. 4. Comparison of the distributions of amino acid changes at
each position in the V3 loop between postmortem sequences and those
of NSI/MT isolates (solid line) and those of SI/T-cell-tropic isolates
(dotted line) in vitro. The probability of the distribution of changes
arising by chance is indicated on the y axis on a log scale. Sequences
compared correspond to those shown in Fig. 3.
dendritic cells and was not found in the T-cell areas of either
presymptomatic or terminal patients with AIDS (Fig. 7b). The
failure to detect p24 antigen staining outside the lymphoid
follicles suggests that the provirus-bearing cells in lymphoid
tissue are largely transcriptionally inactive, although the p24
assay used in this study may not be able to detect low-level
expression of virus proteins.
Elsewhere, p24 antigen-expressing cells in vivo were found
in brain (Fig. 7c and d), spinal cord, and lung tissue (Fig. 7f and
h). In brain and spinal cord tissues of patients with AIDS, p24
antigen was detected in multinucleated giant cells (Fig. 7c), in
mononuclear macrophages, and frequently in morphologically
normal microglial cells (Fig. 7d). In general, the presence of
p24 antigen-positive cells was associated topographically with
evidence of tissue damage.
In the lung tissue of patient 4, frequent p24 antigen-
expressing lung macrophages were found, and, as in the brain,
infected cells formed pronounced multinucleated syncytia (Fig.
7f). For this patient, the predominant V3 sequence of provirus
amplified from lung tissue was identical to the major variants
infecting the brain and spinal cord and to a proportion of those
in colon tissue (Fig. 2). However, this sequence was not
represented significantly among sequences of provirus infect-
ing lymphoid tissue from the same patient. The other patient
who by quantitative PCR (patient 5; Table 1) showed signifi-
cant infection of the lungs showed a sharply contrasting tissue
distribution of infection. Pathological examination of the lung
revealed prominent lymphocytic infiltration into lung tissue
and formation of poorly formed lymphoid follicles adjacent to
bronchioles (Fig. 7g and h). p24 antigen was detected within
the lymphoid follicles but not elsewhere in the lung despite the
presence of some multinucleated macrophages. In this patient
the population of V3 sequences in lung tissue corresponded
closely to that in lymphoid tissue and was distinct from that of
provirus variants infecting the brain, where infection of mac-
rophages and microglial cells was prominent (Fig. 2).
DISCUSSION
Restricted sequence variability in the V3 region. An unan-
ticipated finding in this study was the limited sequence vari-
ability in the V3 loop of HIV amplified from tissues in vivo.
This restriction was evident irrespective of the degree of
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FIG. 5. Comparison of V3 loop sequences on the basis of predicted
overall charge (x axis) and number of amino acid changes from the
subtype B consensus (40) (y axis). (a) Fifty-nine isolates of known
phenotype in vitro; 0, NSI and MT; 0, SI, non-MT. See legend to Fig.
3 for sources of sequences. A diagonal line separates the two popula-
tions. Equivalent analysis was carried out upon the nonidentical V3
loop sequences collected postmortem from three presymptomatic
individuals (b) and four patients who died from complications associ-
ated with AIDS (c). Origins of sequences: 0, PBNCs, OI, lymph nodes;
+, brain; *, spinal cord; 0, lung; *, colon. The V3 loop charge was
calculated by assigning a unitary positive charge to arginine and lysine
residues and a unitary negative charge to glutamate and aspartate
residues. The potential partial charge contributed by histidine residues
was discounted.
J. VIROL.
RESTRICTED SEQUENCE VARIABILITY OF V3 IN VIVO 5999
TABLE 5. Detectiona of p24 antigen in postmortem tissue
Staining result
Patient Lymphoid tissue Nonlymphoid tissue
Lymph Spleen Brain Spinal Lung
node cord
Asymptomatic
1 + + - _ _
2 +++ +++ - _ _
3 NDb - _ _ _
Symptomatic
4 ND - ++ ++ +++
5 +++ ++ +++ +++ ++
6 - - ++ _
9 ND ++ +++ - -
a Graded from - (negative) to +++ (extensive staining, frequent antigen-
expressing cells).b ND, not done.
disease progression and tissue origin, whether lymphoid or
nonlymphoid. Both the consensus and observed polymor-
phisms almost exactly matched those found in a separate
analysis of isolates showing an MT/NSI phenotype in vitro, but
were quite distinct from those of SI variants (Fig. 4). The
infrequency with which variants with a predicted SI phenotype
were detected in vivo contrasts with their frequent isolation
from patients upon disease progression (3, 8, 18, 74). For
example, among the four patients with AIDS in this study, only
two variants were found to show sufficient positive charge and
divergence from the consensus sequence to place over the
dividing line that separates isolates with different properties
(Fig. 5c).
We were able to rule out two possible sources of bias in our
results, i.e., that the primers used for amplification of the V3
loop preferentially amplified NSI variants, and that we were
studying an epidemiologically very restricted group of patients.
To address the first possibility, we compared quantitation of
proviral sequences by using primers specific for both V3 and
the well conserved pol region. Evaluating the likelihood func-
tion to determine confidence intervals for the quantitation
method used in this study, we found no significant differences
between virus loads when we used the two sets of PCR primers.
These data make it unlikely that we failed to amplify a
significant proportion of envelope sequences and, indeed, the
close concordance between the results for pol and V3 in every
sample further suggests that each of the sequences analyzed
was derived from a complete provirus (see below).
The second potential bias was addressed by phylogenetic
analysis of pl79a9 sequences from the 11 patients from whom
we obtained V3 loop sequences. This analysis suggested that
the individuals were infected with a representative range of
HIV-1 subtype B variants and that the similarities observed in
the V3 loop did not result simply from infection with relatively
homogeneous and possibly epidemiologically related variants.
The high frequency of variants with a predicted NSI pheno-
type is not inconsistent with the results of previous studies.
Variants with predicted NSI phenotypes were frequently de-
tected in several published analyses of viral sequences in vivo,
in many cases from patients with advanced HIV-related dis-
ease (16, 28, 33, 37, 51, 56, 62, 67, 80, 81, 86), although their
frequency relative to SI variants varies considerably between
patient groups. Sequence comparisons of the V3 loop of
HIVELI
FIG. 6. Phylogenetic analysis of sequences in the p179a9 gene of the study patients, and comparison with V3 loop sequence diversity. (Left
panel) Phylogenetic relationships represented by a rooted tree, with the HIV-1 subtype D sequence ELI as an outgroup. 0, study patients; 0, other
HIV-infected Edinburgh patients. (Right panel) Majority amino acid sequence from PBNCs (P) or lymph node (L) of samples from study patients
in the V3 loop; only differences from the subtype B consensus sequences (40) are shown (see legend to Fig. 2).
Cons ICTRPNNNTRKSIHIGPGRAFYTTGEIIGDIRQAHC -
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FIG. 7. Morphology and immunocytochemical detection of p24 antigen in lymphoid and nonlymphoid tissue. (a) Lymph node of patient 2
(asymptomatic) at low magnification (X31); hematoxylin and eosin stain. Normal germinal centers are set in the lymphocyte cortex (arrows). (b)
High-magnification (x 193) view of the same lymph node stained for p24 antigen, showing association of viral protein with follicular dendritic cells.
(c) High-magnification view of section of frontal lobe of the brain from patient 5, stained for p24 antigen, showing prominent virus expression in
giant (syncytial) cells (nuclei indicated by arrows; x308). (d) Same case showing p24 positivity in cells of microglial morphology (arrows; x 193).
(e) Section of lung from patient 4 showing frequent macrophage syncytia (arrows) in lung alveoli filled with mononuclear macrophages and edema
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sequential samples collected upon disease progression often
show a change from a predicted NSI to SI phenotype (80),
although there is no evidence for a complete replacement. For
example, in an HIV-infected hemophiliac monitored over a
period of 6 years, V3 loop sequences were NSI in early
infection and became predominantly SI between 4 and 5 years
after infection but subsequently reverted to an apparent NSI
phenotype (28, 69).
The observed restriction in sequence variability of the V3
loop can be plausibly accounted for by strong selection against
sequence change in this region, although with some tolerance
of certain amino acid replacements at specific sites (28, 51).
The mechanism of selection for these variants remains obscure
(see below), but it is significant that exactly the same restriction
in sequence diversity in the V3 loop in variants associated with
primary infection has been observed in vivo (38, 85, 87).
In vitro phenotype of HIV. Although we have not been able
to confirm the phenotype of the postmortem variants experi-
mentally, direct evidence that variants found in the CNS were
indeed MT has been reported by others (9, 33). In one study,
it was found that almost all isolates derived from the cerebro-
spinal fluid from a range of asymptomatic and symptomatic
individuals were capable of efficient replication in primary
macrophage culture (33); these variants showed V3 loop
sequences with low charge and little divergence, if any, from
the subtype B consensus.
Most of the published sequences of SI variants used for
sequence comparisons were derived from isolates of HIV-1
that were often passaged extensively in cell culture prior to
biological characterization. It is possible that whatever selec-
tive constraint restricts sequence diversity in vivo is absent in
the conditions used for virus culture and that the virus is
therefore free to drift away from the subtype B consensus
sequence. It is also possible that a V3 (or V2) loop with a large
positive charge confers a growth advantage in vitro, leading to
the selective isolation of variants bearing such divergent se-
quences from a heterogeneous in vivo population. Indeed, the
isolation of SI variants from patients progressing to AIDS is
associated with increased virus load and therefore with a
greater likelihood that such extreme variants might by chance
be present in the initial PBMC culture.
Changes in the properties of isolates upon in vitro passaging
are commonly observed. Repeated passaging enables HIV to
adapt to efficient replication in different cell types, including
permanently transformed T-cell lines. It has also been shown
that in vitro culture leads to a rapid loss of sequence variability
in the env gene (39) and often to the replacement of the
predominant in vivo variant with a minor population (37, 39,
50). Indeed, specific outgrowth of SI variants has been found
upon short-term primary lymphocyte culture of PBMCs with
V3 loop sequences that could be predicted to be mainly
NSI/MT (37, 47a, 61). These data are consistent with the
hypothesis that the overrepresentation of SI isolates from
patients with AIDS compared with their frequency in vivo is at
least in part the direct result of their competitive advantage
over NSI/MT variants in certain in vitro culture conditions and
therefore does not necessarily reflect their prevalence in vivo.
Other lentiviruses such as HIV-2 and several of the simian
immunodeficiency viruses (SIV) have envelope proteins with
many structural similarities to HIV-1 gpl60. In particular, it is
possible to identify the homologs of the V1/V2 and V4
hypervariable regions in these different viruses. One puzzling
feature has been the low degree of sequence variability in the
counterpart of the HIV-1 V3 loop in HIV-2 and SIVmac (1, 7,
66). The results in this paper suggest that the designation of V3
as a hypervariable region may have been unduly influenced by
the characteristics of cultured isolates of HIV-1 and may not
reflect the relative homogeneity of sequences in this region in
vivo. The similarities between HIV-1 and other lentiviruses
may be greater than were previously imagined.
In vivo phenotype of HIV. The sensitive and specific detec-
tion of actively replicating virus in cells by immunocytochem-
ical staining for p24 antigen provided an opportunity to
identify the main target cells of the sequence variants identi-
fied in this study in vivo and their associated cytopathology.
The only infected cells that could be identified by this tech-
nique were tissue macrophages in the lung and either macro-
phages or microglial cells in the CNS. This macrophage
infection was associated with tissue damage and with frequent
giant cell formation.
In contrast, infected cells in the lymph node were not
detected despite the detection of high frequencies of proviral
sequences in DNA extracted from lymphoid tissue in both
presymptomatic patients and those with AIDS. These findings,
however, are consistent with previous reports of extensive but
latent infection in lymphoid tissue (14), which were based upon
the finding that the number of provirus-bearing cells within a
lymph node greatly exceeded the number of those in which
viral RNA sequences could be detected (58). Proviral loads
calculated in this study and in others using similar techniques
(58) range from 102 to 2 x 104 copies per 106 cells. These
figures are not inconsistent with the reported high frequencies
of provirus-bearing cells detected by in situ PCR (14, 15), as
the former figures are for total lymph node DNA, which
includes nucleic acids from cells not susceptible to HIV
infection (B cells, follicular dendritic cells, cells within connec-
tive tissue, etc.).
The reason why HIV infection is largely latent in lymphoid
tissue remains unclear. One possibility is that the DNA de-
tected by PCR is partially reverse-transcribed provirus pro-
duced within extracellular virions (45, 75, 84). Alternatively,
the DNA may be in the form of intracellular (cytoplasmic)
partial transcripts previously observed in vitro upon exposure
of HIV to cells that are nonpermissive for infection (21, 82,
83). As first-strand synthesis of provirus proceeds from the 3'
end of the genomic RNA, transcripts for the 3' long terminal
repeat and env should be relatively more abundant than
transcripts of the pol and gag genes, as has been documented in
vitro (82, 84). However, in this study careful quantitation by
limiting-dilution PCR with nested primers showed no differ-
ence in the relative frequencies of V3 and pol region se-
quences, irrespective of whether the samples were from tissue
of lymphoid or nonlymphoid origin (Tables 1 and 2; Fig. 1);
this suggests strongly that the sequences detected and se-
quenced in this study originated from complete proviruses.
HIV tropism in vivo. We were unable to differentiate
variants in this study in terms of SI/NSI phenotype, as all
showed similar low charge and high degree of sequence
conservation in the V3 loop. However, it was evident that
differences existed in the populations of variants infecting
fluid (x77). (f) High-magnification (x 193) view showing p24 antigen-expressing syncytia in the walls of alveoli. (g) Section of lung from patient
5 showing prominent lymphocytic infiltration (arrow) and containing carbon debris. The lung alveoli are partially filled with edema fluid (X77).
(h) Distribution of p24 antigen within lung lymphoid tissue (arrow), similar to that observed in lymph nodes and spleen tissue.
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different organs. For example, no patient showed equivalent
distributions of variants in the CNS and in lymphoid tissue.
Although it is possible to document rapid turnover of env
sequence variants with time in plasma of HIV-infected indi-
viduals (69, 79), little if anything is understood about the
dynamics of sequence change outside the peripheral circula-
tion. In particular, it is not known if separate populations of
HIV develop in isolation from variants in other parts of the
body (local evolution) or whether there is a process of contin-
uous infection and spread from variants circulating in the
blood (systemic evolution). Local evolution in nonlymphoid
tissues might follow the widespread dissemination of HIV
upon primary infection and persist at a low level (undetectable
by PCR or by immunocytochemical staining) throughout the
asymptomatic phase of infection because of cytotoxic T-cell
activity or other immune effector mechanisms. This restriction
on virus replication would become increasingly ineffective
upon progression; the reactivation of virus replication in
nonlymphoid tissue would form the basis for the previously
observed redistribution of HIV in patients with AIDS (5, 13).
In this model, different populations would develop in different
tissues, through evolutionary drift and possibly through specific
adaptive changes for replication in different cell types.
However, a consistent feature of the sequence distributions
in this study and in others was the dispersed nature of many of
the variants. For example, for many of the study patients, the
major components of populations in brain and other nonlym-
phoid samples were often found as minor variants in lymphoid
tissue (and vice versa), suggesting repeated traffic of virus
between the two in patients who were severely immunosup-
pressed. These findings are more consistent with the hypoth-
esis of systemic evolution of HIV, in which virus variants
disseminate freely throughout different tissues in the later
stages of infection and restrict the development of local
populations.
One method of virus spread documented in this paper is by
lymphocyte infiltration of a tissue. In patient 5, the high
proviral load detected by quantitative PCR resulted from the
formation of differentiated lymphoid tissue within the lung and
was associated with the presence of a virus population which
was indistinguishable from that in lymph nodes and spleen
tissue. In contrast, widespread dissemination of infected mac-
rophages most plausibly accounts for the sequence similarity
between variants infecting lung, colon, and brain tissue in
patient 4, since the sequence identity of the V3 loop would be
unlikely to have arisen by chance at several sites in the body, as
would be necessary in the local model of evolution.
What remains unclear is whether variants associated with
infected macrophages are functionally distinct from those
found in lymphoid tissue. We are currently investigating this
question through further sequence comparisons of different
parts of the env gene, and through in vitro characterization of
isolates derived from lymphocyte- and macrophage-infiltrated
tissues.
This study provides no information on the possible origins or
fate of syncytium-inducing variants of HIV that are frequently
isolated upon disease progression. In this study, not only did
we fail to detect variants with a predicted SI phenotype in the
patients with AIDS, but the observed behavior of HIV in vivo
consistently differed from that observed with cultures. Immu-
nocytochemical staining for p24 antigen in the CNS (and lung
tissue) of the patients with AIDS revealed cytopathic infection
of macrophage/microglial cells by variants with a predicted NSI
phenotype. These findings suggest that in vivo observations of
giant cell formation are not reproduced by infection of cell
lines such as MT-2. Furthermore, the ability of HIV to infect
macrophages is not lost with disease progression as was
previously suggested (10, 63). Indeed, the findings in this paper
appear more consistent with previous findings that progression
is accompanied by a change in the phenotype of isolates to SI
variants that retain an ability to replicate in primary macro-
phage culture (8).
Independent evidence for the importance of macrophage
tropism in pathogenesis has been obtained from observations
of a more rapid CD4+ lymphocyte depletion in SCID-Hu mice
infected with an MT variant than in those infected with SF-2
(53). In another animal model, the lack of disease progression,
the stable CD4+ count, and the low circulating virus loads in
chimpanzees infected with HIV-1 were attributed to a species-
specific inability of HIV to infect chimpanzee macrophages
(65). Directly or indirectly, the investigations described in this
communication may contribute to our understanding of the
mechanism by which T cells become depleted, the influence of
macrophage infection, and the role of infection in the lymph
nodes and spleen. These questions are essential for under-
standing the pathogenesis of HIV infection but are currently
unresolved.
ACKNOWLEDGMENTS
We thank staff in the Department of Neuropathology and Medical
Microbiology, University of Edinburgh, for technical assistance in
storage and preparation of postmortem samples used in this study.
This work was funded by grants awarded by the Medical Research
Council to P.S. (PG 9209918 with A. J. Leigh Brown) and to J.E.B.
(SPG 8925719).
REFERENCES
1. Almond, N., A. Jenkins, A. B. Heath, and P. Kitchin. 1993.
Sequence variation in the env gene of simian immunodeficiency
virus recovered from immunized macaques is predominantly in the
Vl region. J. Gen. Virol. 74:865-871.
2. Andeweg, A. C., P. Leeflang, A. D. M. E. Osterhaus, and M. L.
Bosch. 1993. Both the V2 and V3 regions of the human immuno-
deficiency virus type 1 surface glycoprotein functionally interact
with other envelope regions in syncytium formation. J. Virol.
67:3232-3239.
3. Asjo, B., J. Albert, A. Karisson, L. Morfeldt Manson, G. Biberfeld,
K. Lidman, and E. M. Fenyo. 1986. Replicative properties of
human immunodeficiency virus from patients with varying severity
of HIV infection. Lancet ii:660-662.
4. Balfe, P., P. Simmonds, C. A. Ludlam, J. 0. Bishop, and A. J.
Leigh Brown. 1990. Concurrent evolution of human immunodefi-
ciency virus type 1 in patients infected from the same source: rate
of sequence change and low frequency of inactivating mutations. J.
Virol. 64:6221-6233.
5. Bell, J. E., A. Busittil, J. W. Ironside, S. Rebus, Y. K. Donaldson,
P. Simmonds, and J. F. Peutherer. 1993. Human immunodefi-
ciency virus and the brain: investigation of virus load and neuro-
pathological changes in pre-AIDS individuals. J. Infect. Dis.
168:818-824.
6. Boyd, M. T., G. R. Simpson, A. J. Cann, M. A. Johnson, and R. A.
Weiss. 1993. A single amino acid substitution in the Vl loop of
human immunodeficiency virus type 1 gpl20 alters cellular tro-
pism. J. Virol. 67:3649-3652.
7. Burns, D. P., and R. C. Desrosiers. 1991. Selection of genetic
variants of simian immunodeficiency virus in persistently infected
rhesus monkeys. J. Virol. 65:1843-1854.
8. Cheng-Mayer, C., D. Seto, M. Tateno, and J. A. Levy. 1988.
Biological features of HIV-1 that correlate with virulence in the
host. Science 240:80-82.
9. Cheng-Mayer, C., C. Weiss, D. Seto, and J. A. Levy. 1989. Isolates
of human immunodeficiency virus type 1 from brain may consti-
tute a special group of the AIDS virus. Proc. Natl. Acad. Sci. USA
86:8575-8579.
10. Chesebro, B., K. Wehrly, J. Nishio, and S. Perryman. 1992.
Macrophage-tropic human immunodeficiency virus isolates from
J. VIROL.
RESTRICTED SEQUENCE VARIABILITY OF V3 IN VIVO 6003
different patients exhibit unusual V3 envelope sequence homoge-
neity in comparison with T cell-tropic isolates: definition of critical
amino acids involved in cell tropism. J. Virol. 66:6547-6554.
11. de Jong, J. J., A. de Ronde, W. Keulen, M. Tersmette, and J.
Goudsmit. 1992. Minimal requirements for the human immuno-
deficiency virus type 1 V3 domain to support the syncytium-
inducing phenotype: analysis by single amino acid substitution. J.
Virol. 66:6777-6780.
12. de Jong, J. J., J. Goudsmit, W. Keulen, B. Klaver, W. Krone, M.
Tersmette, and A. de Ronde. 1992. Human immunodeficiency
virus type 1 clones chimeric for the envelope V3 domain differ in
syncytium formation and replication capacity. J. Virol. 66:757-765.
13. Donaldson,Y. K., J. E. Bell, J. W. Ironside, R. P. Brettle, J. R.
Robertson, A. Busuttil, and P. Simmonds. 1994. Redistribution of
human immunodeficiency virus outside the lymphoid system with
the onset of AIDS. Lancet 343:382-385.
14. Embretson, J., M. Zupancic, J. Beneke, M. Till, S. Wolinsky, J. L.
Ribas, A. Burke, and A. T. Haase. 1993. Analysis of human
immunodeficiency virus-infected tissues by amplification and in-
situ hybridization reveals latent and permissive infections at
single-cell resolution. Proc. Natl. Acad. Sci. USA 90:357-361.
15. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K.
Tennerracz, and A. T. Haase. 1993. Massive covert infection of
helper T lymphocytes and macrophages by HIV during the
incubation period of AIDS. Nature (London) 362:359-362.
16. Epstein, L. G., C. Kuiken, B. M. Blumberg, S. Hartman, L. R.
Sharer, M. Clement, and J. Goudsmit. 1991. HIV-1 V3 domain
variation in brain and spleen of children with AIDS: tissue-specific
evolution within host-determined quasispecies. Virology 180:583-
590.
17. Felsenstein, J. 1989. PHYLIP-phylogeny inference package (ver-
sion 3.2). Cladistics 5:164-166.
18. Fenyo, E. M., L. Morfeldt-Manson, F. Chiodi, B. Lind, A. von
Gegerfelt, J. Albert, E. Olausson, and B. Asjo. 1988. Distinct
replicative and cytopathic characteristics of human immunodefi-
ciency virus isolates. J. Virol. 62:4414-4419.
19. Fouchier, R. A. M., M. Groenink, N. A. Kootstra, M. Tersmette,
H. G. Huisman, F. Miedema, and H. Schuitemaker. 1992. Pheno-
type-associated sequence variation in the third variable domain of
the human immunodeficiency virus type 1 gpl20 molecule. J.
Virol. 66:3183-3187.
20. Fung, M. S., C. R. Sun, W. L. Gordon, R. S. Liou, T. W. Chang,
W. N. Sun, E. S. Daar, and D. D. Ho. 1992. Identification and
characterization of a neutralization site within the second variable
region of human immunodeficiency virus type 1 gpl20. J. Virol.
66:848-856.
21. Gao, W. Y., A. Cara, R. C. Gallo, and F. Lori. 1993. Low levels of
deoxynucleotides in peripheral blood lymphocytes-a strategy to
inhibit human immunodeficiency virus type-1 replication. Proc.
Natl. Acad. Sci. USA 90:8925-8928.
22. Gartner, S., P. Markovits, D. M. Markovitz, H. Kaplan, R. C.
Gallo, and M. Popovic. 1986. The role of mononuclear phagocytes
in HTLV-III/LAV infection. Science 233:215-219.
23. Gendelman, H. E., L. M. Baca, H. Husayni, J. A. Turpin, D.
Skillman, D. C. Kalter, J. M. Orenstein, D. L. Hoover, and M. S.
Meltzer. 1990. Macrophage-HIV interaction: viral isolation and
target cell tropism. AIDS 4:221-228.
24. Groenink, M., R. A. M. Fouchier, S. Broersen, C. H. Baker, M.
Koot, A. B. van't Wout, H. G. Huisman, F. Miedema, M. Ters-
mette, and H. Schuitemaker. 1993. Relation of phenotype evolu-
tion of HIV-1 to envelope V2 configuration. Science 260:1513-1516.
25. Haggerty, S., and M. Stevenson. 1991. Predominance of distinct
viral genotypes in brain and lymph node compartments of HIV-
infected individuals. Viral Immunol. 4:123-131.
26. Haigwood, N. L., J. R. Shuster, G. K. Moore, H. Lee, P. V. Skiles,
K. W. Higgins, P. J. Barr, C. George Nascimento, and K. S.
Steimer. 1990. Importance of hypervariable regions of HIV-1
gpl20 in the generation of virus neutralizing antibodies. AIDS
Res. Hum. Retroviruses 6:855-869.
27. Holmes, E. C., A. J. L. Brown, and P. Simmonds. 1993. Sequence
data as evidence. Nature (London) 364:766.
28. Holmes, E. C., L. Q. Zhang, P. Simmonds, C. A. Ludlam, and A. J.
Leigh Brown. 1992. Convergent and divergent sequence evolution
in the surface envelope glycoprotein of human immunodeficiency
virus type 1 within a single infected patient. Proc. Natl. Acad. Sci.
USA 89:4835-4839.
29. Holmes, E. C., L. Q. Zhang, P. Simmonds, A. S. Rogers, and
A. J. L. Brown. 1993. Molecular investigation of human immuno-
deficiency virus (HIV) infection in a patient of an HIV-infected
surgeon. J. Infect. Dis. 167:1411-1414.
29a.Holmes, E. C., et al. Unpublished data.
30. Hultman, T., S. Stahl, E. Hornes, and M. Uhlen. 1989. Direct
solid-phase sequencing of genomic and plasmid DNA using mag-
netic beads as solid support. Nucleic Acids Res. 17:4937-4946.
31. Hwang, S. S., T. J. Boyle, H. K. Lyerly, and B. R. Cullen. 1991.
Identification of the envelope V3 loop as the primary determinant
of cell tropism in HIV-1. Science 253:71-74.
32. Javaherian, K., A. J. Langlois, G. J. LaRosa, A. T. Profy, D. P.
Bolognesi, W. C. Herlihy, S. D. Putney, and T. J. Matthews. 1990.
Broadly neutralizing antibodies elicited by the hypervariable neu-
tralizing determinant of HIV-1. Science 250:1590-1593.
33. Keys, B., J. Karis, B. Fadeel, A. Valentin, G. Norkrans, L.
Hagberg, and F. Chiodi. 1993. V3 sequences of paired HIV-1
isolates from blood and cerebrospinal fluid cluster according to
host and show variation related to the clinical stage of disease.
Virology 196:475-483.
34. Koenig, S., H. E. Gendelman, J. M. Orenstein, M. C. Dal Canto,
G. H. Pezeshkpour, M. Yungbluth, F. Janotta, A. Aksamit, M. A.
Martin, and A. S. Fauci. 1986. Detection of AIDS virus in
macrophages in brain tissue from AIDS patients with encephalop-
athy. Science 233:1089-1093.
35. Koot, M., I. P. M. Keet, A. H. V. Vos, R. E. Y. Degoede, M. T. L.
Roos, R. A. Coutinho, F. Miedema, P. T. A. Schellekens, and M.
Tersmette. 1993. Prognostic value of HIV-1 syncytium-inducing
phenotype for rate of CD4+ cell depletion and progression to
AIDS. Ann. Intern. Med. 118:681-688.
36. Koyanagi, Y., S. Miles, R. T. Mitsuyasu, J. E. Merrill, H. V.
Vinters, and I. S. Chen. 1987. Dual infection of the central nervous
system by AIDS viruses with distinct cellular tropisms. Science
236:819-822.
37. Kuiken, C. L., J.-J. de Jong, E. Baan, W. Keulen, M. Tersmette,
and J. Goudsmit. 1992. Evolution of the V3 envelope domain in
proviral sequences and isolates of human immunodeficiency virus
type 1 during transition of the viral biological phenotype. J. Virol.
66:4622-4627.
38. Kuiken, C. L., G. Zwart, E. Baan, R. A. Coutinho, J. A. R.
Vandenhoek, and J. Goudsmit. 1993. Increasing antigenic and
genetic diversity of the v3 variable domain of the human immu-
nodeficiency virus envelope protein in the course of the AIDS
epidemic. Proc. Natl. Acad. Sci. USA 90:9061-9065.
39. Kusumi, K., B. Conway, S. Cunningham, A. Berson, C. Evans,
A. K. N. Iversen, D. Colvin, M. V. Gallo, S. Coutre, E. G. Shpaer,
D. V. Faulkner, A. deRonde, S. Volkman, C. Williams, M. S.
Hirsch, and J. I. Mullins. 1992. Human immunodeficiency virus
type 1 envelope gene structure and diversity in vivo and after
cocultivation in vitro. J. Virol. 66:875-885.
40. LaRosa, G. J., J. P. Davide, K. Weinhold, J. A. Waterbury, A. T.
Profy, J. A. Lewis, A. J. Langlois, G. R. Dreesman, R. N. Boswell,
and P. Shadduck 1990. Conserved sequence and structural ele-
ments in the HIV-1 principal neutralizing determinant. Science
249:932-935.
41. Levy, J. A. 1993. Pathogenesis of human immunodeficiency virus
infection. Microbiol. Rev. 57:183-289.
42. Li, Y. X., J. C. Kappes, J. A. Conway, R. W. Price, G. M. Shaw, and
B. H. Hahn. 1991. Molecular characterization of human immuno-
deficiency virus type 1 cloned directly from uncultured human
brain tissue: identification of replication-competent and -defective
viral genomes. J. Virol. 65:3973-3985.
43. Liu, Z.-Q., C. Wood, J. A. Levy, and C. Cheng-Mayer. 1990. The
viral envelope gene is involved in macrophage tropism of a human
immunodeficiency virus type 1 strain isolated from brain tissue. J.
Virol. 64:6148-6153.
44. Looney, D. J., A. G. Fisher, S. D. Putney, J. R. Rusche, R. R.
Redfield, S. D. Burke, R. C. Gallo, and F. Wong Staal. 1988. Type
restricted neutralization of molecular clones of HIV. Science
241:357-359.
VOL. 68, 1994
6004 DONALDSON ET AL.
45. Lori, F., F. di Marzo Veronese, A. L. De Vico, P. Lusso, M. S. Reitz,
Jr., and R. C. Gallo. 1992. Viral DNA carried by human immu-
nodeficiency virus type 1 virions. J. Virol. 66:5067-5074.
46. Louwagie, J., F. E. McCutchan, M. Peeters, T. P. Brennan, E.
Sandersbuell, G. A. Eddy, G. Vandergroen, K. Fransen, G. M.
Gershydamet, R. Deleys, and D. S. Burke. 1993. Phylogenetic
analysis of gag genes from 70 international HIV-1 isolates pro-
vides evidence for multiple genotypes. AIDS 7:769-780.
47. Macatonia, S. E., R. Lau, S. Patterson, A. J. Pinching, and S. C.
Knight. 1990. Dendritic cell infection, depletion and dysfunction
in HIV-infected individuals. Immunology 71:38-45.
47a.Mayer, A. Personal communication.
48. Mehta, C. R., and N. R. Patel. 1993. A network algorithm for
performing Fisher's exact test in r x c contingency tables. J. Am.
Stat. Assoc. 78:427-434.
49. Meloen, R. H., R. M. Liskamp, and J. Goudsmit. 1989. Specificity
and function of the individual amino acids of an important
determinant of human immunodeficiency virus type 1 that induces
neutralizing activity. J. Gen. Virol. 70:1505-1512.
50. Meyerhans, A., R. Cheynier, J. Albert, M. Seth, S. Kwok, J.
Sninsky, L. Morfeldt Manson, B. Asjo, and S. Wain Hobson. 1989.
Temporal fluctuations in HIV quasispecies in vivo are not re-
flected by sequential HIV isolations. Cell 58:901-910.
51. Milich, L., B. Margolin, and R. Swanstrom. 1993. V3 loop of the
human immunodeficiency virus type 1 Env protein: interpreting
sequence variability. J. Virol. 67:5623-5634.
52. Modrow, S., B. H. Hahn, G. M. Shaw, R. C. Gallo, F. Wong-Staal,
and H. Wolf. 1987. Computer-assisted analysis of envelope protein
sequences of seven human immunodeficiency virus isolates: pre-
diction of antigenic epitopes in conserved and variable regions. J.
Virol. 61:570-578.
53. Mosier, D. E., R. J. Gulizia, P. D. Macisaac, B. E. Torbett, and
J. A. Levy. 1993. Rapid loss of CD4+ T cells in human-PBL-SCID
mice by noncytopathic HIV isolates. Science 260:689-692.
54. Myers, G., B. Korber, J. Berzofsky, T. F. Smith, and G. N.
Pavlakis. 1991. Human retroviruses and AIDS 1993. Los Alamos
National Laboratory, Los Alamos, N.M.
55. Nicholson, J. K., G. D. Cross, C. S. Callaway, and J. S. McDougal.
1986. In vitro infection of human monocytes with human T
lymphotropic virus type III/lymphadenopathy-associated virus
(HTLV-III/LAV). J. Immunol. 137:323-329.
56. Ou, C. Y., C. A. Ciesielski, G. Myers, C. I. Bandea, C. C. Luo, B. T.
Korber, J. I. Mullins, G. Schochetman, R. L. Berkelman, and A. N.
Economou. 1992. Molecular epidemiology of HIV transmission in
a dental practice. Science 256:1165-1171.
57. Pang, S., H. V. Vinters, T. Akashi, W. A. OBrien, and I. S. Chen.
1991. HIV-1 env sequence variation in brain tissue of patients with
AIDS-related neurologic disease. J. Acquired Immune Defic.
Syndr. 4:1082-1092.
58. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni,
C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993.
HIV infection is active and progressive in lymphoid tissue during
the clinically latent stage of disease. Nature (London) 362:355-
358.
59. Roos, M. T. L., J. M. A. Lange, R. E. Y. Goede, R. A. Coutinho,
P. T. A. Schellekens, F. Miedema, and M. Tersmette. 1992. Viral
phenotype and immune response in primary human immunodefi-
ciency virus type 1 infection. J. Infect. Dis. 165:427-432.
60. Rusche, J. R., K. Javaherian, C. McDanal, J. Petro, D. L. Lynn, R.
Grimaila, A. Langlois, R. C. Gallo, L. 0. Arthur, P. J. Fischinger,
D. P. Bolognesi, S. D. Putney, and T. J. Matthews. 1988. Antibod-
ies that inhibit fusion of human immunodeficiency virus-infected
cells bind a 24-amino-acid sequence of the viral envelope, gpl20.
Proc. Natl. Acad. Sci. USA 85:3198-3202.
61. Sanchez-Palomino, S., J. M. Rojas, M. A. Martinez, E. M. Fenyo,
R. Najera, E. Domingo, and C. L6pez-Galindez. 1993. Dilute
passage promotes expression of genetic and phenotypic variants of
human immunodeficiency virus type 1 in cell culture. J. Virol.
67:2938-2943.
62. Scarlatti, G., T. Leitner, E. Halapi, J. Wahlberg, P. Marchisio,
M. A. Clericischoeller, H. Wigzell, E. M. Fenyo, J. Albert, M.
Uhlen, and P. Rossi. 1993. Comparison of variable region-3
sequences of human immunodeficiency virus type-1 from infected
children with the RNA and DNA sequences of the virus popula-
tions of their mothers. Proc. Natl. Acad. Sci. USA 90:1721-1725.
63. Schuitemaker, H., M. Koot, N. A. Kootstra, M. W. Dercksen,
R. E. Y. de Goede, R. P. van SteenwiJk, J. M. A. Lange, J. K. M. E.
Schattenkerk, F. Miedema, and M. Tersmette. 1992. Biological
phenotype of human immunodeficiency virus type 1 clones at
different stages of infection: progression of disease is associated
with a shift from monocytotropic to T-cell-tropic virus popula-
tions. J. Virol. 66:1354-1360.
64. Schuitemaker, H., N. A. Kootstra, R. E. Y. de Goede, F. de Wolf,
F. Miedema, and M. Tersmette. 1991. Monocytotropic human
immunodeficiency virus type 1 (HIV-1) variants detectable in all
stages of HIV-1 infection lack T-cell line tropism and syncytium-
inducing ability in primary T-cell culture. J. Virol. 65:356-363.
65. Schuitemaker, H., L. Meyaard, N. A. Kootstra, R. Dubbes, S. A.
Otto, M. Tersmette, J. L. Heeney, and F. Miedema. 1993. Lack of
T cell dysfunction and programmed cell death in human immuno-
deficiency virus type-1 infected chimpanzees correlates with ab-
sence of monocytotropic variants. J. Infect. Dis. 168:1140-1147.
66. Sharma, D. P., M. C. Zink, M. Anderson, R. Adams, J. E.
Clements, S. V. Joag, and 0. Narayan. 1992. Derivation of
neurotropic simian immunodeficiency virus from exclusively lym-
phocytotropic parental virus: pathogenesis of infection in ma-
caques. J. Virol. 66:3550-3556.
67. Simmonds, P., P. Balfe, C. A. Ludlam, J. 0. Bishop, and A. J.
Leigh Brown. 1990. Analysis of sequence diversity in hypervariable
regions of the external glycoprotein of human immunodeficiency
virus type 1. J. Virol. 64:5840-5850.
68. Simmonds, P., P. Balfe, J. F. Peutherer, C. A. Ludlam, J. 0.
Bishop, and A. J. Leigh Brown. 1990. Human immunodeficiency
virus-infected individuals contain provirus in small numbers of
peripheral mononuclear cells and at low copy numbers. J. Virol.
64:864-872.
69. Simmonds, P., L. Q. Zhang, F. McOmish, P. Balfe, C. A. Ludlam,
and A. J. Leigh Brown. 1991. Discontinuous sequence change of
human immunodeficiency virus (HIV) type 1 env sequences in
plasma viral and lymphocyte-associated proviral populations in
vivo: implications for models of HIV pathogenesis. J. Virol. 65:
6266-6276.
70. Starcich, B. R., B. H. Hahn, G. M. Shaw, P. D. McNeely, S.
Modrow, H. Wolf, E. S. Parks, W. P. Parks, S. F. Josephs, R. C.
Gallo, and F. Wong Staal. 1986. Identification and characteriza-
tion of conserved and variable regions in the envelope gene of
HTLV-III/LAV, the retrovirus of AIDS. Cell 45:637-648.
71. Steuler, H., B. Storch Hagenlocher, and B. Wildemann. 1992.
Distinct populations of human immunodeficiency virus type 1 in
blood and cerebrospinal fluid. AIDS Res. Hum. Retroviruses
8:53-59.
72. Sullivan, N., M. Thali, C. Furman, D. D. Ho, and J. Sodroski.
1993. Effect of amino acid changes in the V1/V2 region of the
human immunodeficiency virus type 1 gpl20 glycoprotein on
subunit association, syncytium formation, and recognition by a
neutralizing antibody. J. Virol. 67:3674-3679.
73. Takeuchi, Y., M. Akutsu, K. Murayama, N. Shimizu, and H.
Hoshino. 1991. Host range mutant of human immunodeficiency
virus type 1: modification of cell tropism by a single point mutation
at the neutralization epitope in the env gene. J. Virol. 65:1710-
1718.
74. Tersmette, M., J. M. Lange, R. E. Y. de Goede, F. de Wolf, J. K.
Eeftink Schattenkerk, P. T. Schellekens, R. A. Coutinho, J. G.
Huisman, J. Goudsmit, and F. Miedema. 1989. Association be-
tween biological properties of human immunodeficiency virus
variants and risk for AIDS and AIDS mortality. Lancet 1:983-985.
75. Trono, D. 1992. Partial reverse transcripts in virions from human
immunodeficiency and murine leukemia viruses. J. Virol. 66:4893-
4900.
76. Watkins, B. A., H. H. Dorn, W. B. Kelly, R. C. Armstrong, B. J.
Potts, F. Michaels, C. V. Kufta, and M. Dubois Dalcq. 1990.
Specific tropism of HIV-1 for microglial cells in primary human
brain cultures. Science 249:549-553.
77. Wiley, C. A., R. D. Schrier, J. A. Nelson, P. W. Lampart, and
M. B. A. Oldstone. 1986. Cellular location of human immunode-
ficiency virus infection within the brains of acquired immune
J. VIROL.
RESTRICTED SEQUENCE VARLABILITY OF V3 IN VIVO 6005
deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83:7089-
7093.
78. Willey, R. L., R. A. Rutledge, S. Dias, T. Folks, T. Theodore, C. E.
Buckler, and M. A. Martin. 1986. Identification of conserved and
divergent domains within the envelope gene of the acquired
immunodeficiency syndrome retrovirus. Proc. Natl. Acad. Sci.
USA 83:5038-5042.
79. Wolfs, T. F. W., J. J. de Jong, H. Van den Berg, J. M. Tijnagel,
W. J. Krone, and J. Goudsmit. 1990. Evolution of sequences
encoding the principal neutralization epitope of human immuno-
deficiency virus 1 is host dependent, rapid, and continuous. Proc.
Natl. Acad. Sci. USA 87:9938-9942.
80. Wolfs, T. F. W., G. Zwart, M. Bakker, and J. Goudsmit. 1992.
HIV-1 genomic RNA diversification following sexual and paren-
teral virus transmission. Virology 189:103-110.
81. Wolinsky, S. M., C. M. Wike, B. T. M. Korber, C. Hutto, W. P.
Parks, L. A. Rosenblum, K. J. Kunstman, M. R. Furtado, and J. L.
Munoz. 1992. Selective transmission of human immunodeficiency
virus type-1 variants from mothers to infants. Science 255:1134-
1137.
82. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and
I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lympho-
cytes: molecular analysis reveals a labile, latent structure. Cell
61:213-222.
83. Zack, J. A., A. M. Haislip, P. Krogstad, and I. S. Y. Chen. 1992.
Incompletely reverse-transcribed human immunodeficiency virus
type 1 genomes in quiescent cells can function as intermediates in
the retroviral life cycle. J. Virol. 66:1717-1725.
84. Zhang, H., Y. Zhang, T. P. Spicer, L. Z. Abbott, M. Abbott, and
B. J. Poiesz. 1993. Reverse transcription takes place within extra-
cellular HIV-1 virions: potential biological significance. AIDS Res.
Hum. Retroviruses 9:1287-1296.
85. Zhang, L. Q., P. MacKenzie, A. Cleland, E. C. Holmes, A. J. Leigh
Brown, and P. Simmonds. 1993. Selection for specific sequences in
the external envelope protein of human immunodeficiency virus
type 1 upon primary infection. J. Virol. 67:3345-3356.
86. Zhang, Y. M., S. C. Dawson, D. Landsman, H. C. Lane, and N. P.
Salzman. 1994. Persistence of four related human immunodefi-
ciency virus subtypes during the course of zidovudine therapy:
relationship between virion RNA and proviral DNA. J. Virol.
68:425-432.
87. Zhu, T. F., H. M. Mo, N. Wang, D. S. Nam, Y. Z. Cao, R. A. Koup,
and D. D. Ho. 1993. Genotypic and phenotypic characterization of
HIV-1 in patients with primary infection. Science 261:1179-1181.
VOL. 68, 1994
